Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Software Service, Inc. (3733.T)
JPY10,740.00
-420.00 (-3.76%)
JP JPX Healthcare Medical - Healthcare Information Services
Address
2-6-1, Nishi-Miyahara 532-0004
Osaka, JP
Osaka, JP
CEO
Akihiro Otani
Website
softs.co.jp
IPO
2004-04-29
ISIN JP3436020006
Description
Software Service, Inc. develops and offers solutions such as electronic medical records, comprehensive hospital management platforms, and other related systems. This company was established in 1969 and operates primarily from its headquarters in Osaka, Japan.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY10,740.00
-420.00 (-3.76%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
5.8K
Beta
0.24
Float Shares
2.22M
Free Float %
42.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.71% | +8.44% | -0.60% | -9.69% | -19.67% | -13.80% | -15.19% | +29.89% | +7.84% | +174.58% | +226.55% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
10,740.00
DCF (Unlevered)
37,927.76
+253.1%
DCF (Levered)
27,576.21
+156.8%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
6.43
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
2 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+10.1% Q2'26: +34.6% (vs Q2'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+14.7% Q2'26: +10.0% (vs Q2'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+5.6% Q2'26: +17.9% (vs Q2'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+19.8% ★ Q2'26: +17.8% (vs Q2'25)
-
ROIC Medical - Healthcare Information Services: +5.2%+26.8% ★ Q2'26: +36.8% (vs Q2'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+0.1% ★ Q2'26: -1.9% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×0.00× ★ Q2'26: 0.00× (vs Q2'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Oct 2015 actual |
Oct 2016 actual |
Oct 2017 actual |
Oct 2018 actual |
Oct 2022 actual |
Oct 2023 actual |
Oct 2024 actual |
Oct 2025 actual |
Oct 2026 1 Rev. Ana. 1 EPS Ana. |
Oct 2027 1 Rev. Ana. 1 EPS Ana. |
Oct 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
14.51B
est: 15.50B (-6.4%)
|
17.73B
est: 18.00B (-1.5%)
|
14.62B
est: 16.50B (-11.4%)
|
17.57B
est: 16.00B (+9.8%)
|
27.57B
est: 27.00B (+2.1%)
|
33.72B
est: 33.00B (+2.2%)
|
38.43B
est: 37.50B (+2.5%)
|
42.30B
est: 41.50B (+1.9%)
|
44.30B
44.30B – 44.30B
+6.7% YoY
|
51.00B
51.00B – 51.00B
+15.1% YoY
|
56.00B
56.00B – 56.00B
+9.8% YoY
|
| EBITDA |
3.08B
est: 3.13B (-1.6%)
|
3.21B
est: 3.63B (-11.6%)
|
2.92B
est: 3.33B (-12.3%)
|
3.89B
est: 3.23B (+20.5%)
|
5.25B
est: 5.45B (-3.6%)
|
7.16B
est: 6.66B (+7.5%)
|
7.93B
est: 9.92B (-20.1%)
|
9.27B
est: 10.98B (-15.6%)
|
11.72B
11.72B – 11.72B
+6.7% YoY
|
13.49B
13.49B – 13.49B
+15.1% YoY
|
14.81B
14.81B – 14.81B
+9.8% YoY
|
| EBIT |
2.66B
est: 2.88B (-7.6%)
|
2.83B
est: 3.34B (-15.2%)
|
2.61B
est: 3.06B (-14.9%)
|
3.60B
est: 2.97B (+21.3%)
|
4.85B
est: 5.01B (-3.2%)
|
6.52B
est: 6.13B (+6.4%)
|
7.28B
est: 8.72B (-16.6%)
|
8.39B
est: 9.65B (-13.1%)
|
10.30B
10.30B – 10.30B
+6.7% YoY
|
11.86B
11.86B – 11.86B
+15.1% YoY
|
13.02B
13.02B – 13.02B
+9.8% YoY
|
| Net Income |
1.93B
est: 1.95B (-1.0%)
|
1.91B
est: 1.97B (-2.7%)
|
1.89B
est: 1.57B (+19.9%)
|
2.53B
est: 1.47B (+71.7%)
|
3.40B
est: 3.28B (+3.7%)
|
4.86B
est: 4.10B (+18.5%)
|
5.33B
est: 5.20B (+2.4%)
|
6.11B
est: 5.85B (+4.5%)
|
6.00B
6.00B – 6.00B
+2.6% YoY
|
6.80B
6.80B – 6.80B
+13.3% YoY
|
7.40B
7.40B – 7.40B
+8.8% YoY
|
| SGA |
935.05M
est: 659.63M (+41.8%)
|
969.56M
est: 766.02M (+26.6%)
|
735.36M
est: 702.18M (+4.7%)
|
988.56M
est: 680.91M (+45.2%)
|
1.57B
est: 1.15B (+36.3%)
|
1.70B
est: 1.40B (+21.4%)
|
1.81B
est: 1.99B (-9.4%)
|
1.93B
est: 2.21B (-12.7%)
|
2.35B
2.35B – 2.35B
+6.7% YoY
|
2.71B
2.71B – 2.71B
+15.1% YoY
|
2.98B
2.98B – 2.98B
+9.8% YoY
|
| EPS |
361.96
est: 371.80 (-2.6%)
|
359.32
est: 375.60 (-4.3%)
|
354.14
est: 300.50 (+17.9%)
|
474.62
est: 281.70 (+68.5%)
|
628.61
est: 626.10 (+0.4%)
|
930.35
est: 784.10 (+18.7%)
|
1,018.74
est: 994.10 (+2.5%)
|
1,167.97
est: 1,117.50 (+4.5%)
|
1,146.10
1,146.10 – 1,146.10
+2.6% YoY
|
1,298.90
1,298.90 – 1,298.90
+13.3% YoY
|
1,413.50
1,413.50 – 1,413.50
+8.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-06-05 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-06-04 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-06-03 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-06-02 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-06-01 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
9.10B
OE per share TTM
1,739.52
Owner's Yield
15.33%
Maintenance CapEx ratio
99.08%
Maint CapEx / Avg PPE
58.4%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
4.92M
Shares Outstanding
5.24M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihiro Otani | President & Representative Director | — | male |
| Akira Tamura | Head of Customer Solutions Dept. & Director | — | male |
| Masahiro Kanno | Head of First Systems Department, Head of Advanced Technology Research Laboratory & Director | — | male |
| Yasuaki Matsumoto | Head of Sales Division, Head of Human Resource Department & Director | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 3733.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
